fromilid uno
krka, d.d., novo mesto, slovinsko - klaritromycín - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
biston
zentiva a.s., slovensko - karbamazepín - 21 - antiepileptica, anticonvulsiva
gecrol 5 mg
heaton k.s. - takrolimus - 59 - immunopraeparata
dailiport 5 mg
sandoz pharmaceuticals d.d., slovinsko - takrolimus - 59 - immunopraeparata
dailiport 3 mg
sandoz pharmaceuticals d.d., slovinsko - takrolimus - 59 - immunopraeparata
dailiport 1 mg
sandoz pharmaceuticals d.d., slovinsko - takrolimus - 59 - immunopraeparata
dailiport 0,5 mg
sandoz pharmaceuticals d.d., slovinsko - takrolimus - 59 - immunopraeparata
lunsumio
roche registration gmbh - mosunetuzumab - lymfóm, folikulárny - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.
granisetron b. braun 1 mg/ ml
b.braun melsungen ag, nemecko - granisetrón - 20 - antiemetica, antivertiginosa
kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - iné antineoplastické látky - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.